Reblozyl

Swiss trademark · 757576 · Combined mark · In force

Register entry

Registration number
757576
Application number
00232/2021
Status
In force
Type
Combined mark
As registered
Reblozyl ((fig.))
Filed
Jan 8, 2021
Registered
Jan 11, 2021
Published
Jan 11, 2021
Protected until
Jan 8, 2031
Vienna classes
26.01.01, 26.01.06, 26.01.24, 26.15.01
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate für die Behandlung von Anämie, Beta-Thalassämie, Blutkrankheit, Krebs.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 11, 2021

    Registered

    Published in Swissreg on 11.01.2021

Parties

Holder

Celgene Corporation

86 Morris Avenue, Summit, New Jersey 07901, US

Agent

Troller Hitz Troller, Rechtsanwälte

Schweizerhofquai 2 Postfach, 6002 Luzern

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.